We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GP
14076
PUT
GreenPower Motor Co
GP
$13M
$2.31K ﹤0.01%
100
-2,310
-96% -$63.3K
STRO icon
14077
CALL
Sutro Biopharma
STRO
$340M
$2.31K ﹤0.01%
50
-350
-88% -$22.2K
BWEN icon
14078
PUT
Broadwind
BWEN
$127M
$2.3K ﹤0.01%
600
+500
+500% +$2.13K
HSCSW icon
14079
HeartSciences Inc Warrant
HSCSW
$2.3K ﹤0.01%
10,210
-17,944
-64% -$4.3K
AQMS icon
14080
PUT
Aqua Metals
AQMS
$9.99M
$2.3K ﹤0.01%
12
+3
+33% +$701
FBIO icon
14081
PUT
Fortress Biotech
FBIO
$97.3M
$2.3K ﹤0.01%
+187
New +$2.23K
NTCO
14082
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$2.29K ﹤0.01%
+439
New +$2.32K
ZKIN icon
14083
PUT
ZK International Group
ZKIN
$60.8M
$2.28K ﹤0.01%
500
+443
+777% +$2.44K
EGAN icon
14084
PUT
eGain
EGAN
$206M
$2.28K ﹤0.01%
+300
New +$2.58K
DTEA
14085
CALL
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$2.26K ﹤0.01%
+4,700
New +$4.12K
OPFI icon
14086
PUT
OppFi
OPFI
$610M
$2.25K ﹤0.01%
1,100
-13,500
-92% -$28.4K
CDAK
14087
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$2.22K ﹤0.01%
12,740
-20,208
-61% -$11.2K
EONR.WS
14088
EON Resources Warrants
EONR.WS
$1.43M
$2.22K ﹤0.01%
13,051
-393
-3% -$48
SPMB icon
14089
CALL
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.05B
$2.22K ﹤0.01%
100
-1,000
-91% -$22.1K
HCNEW
14090
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$2.21K ﹤0.01%
+14,281
New +$2.3K
LNSR icon
14091
CALL
LENSAR
LNSR
$101M
$2.21K ﹤0.01%
+900
New +$2.56K
OXSQ icon
14092
CALL
Oxford Square Capital
OXSQ
$157M
$2.21K ﹤0.01%
+700
New +$2.38K
DNA.WS
14093
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$2.21K ﹤0.01%
12,257
+1,469
+14% +$336
VTGN icon
14094
VistaGen Therapeutics
VTGN
$11.9M
$2.2K ﹤0.01%
589
-7,061
-92% -$37K
IVAC
14095
PUT
DELISTED
Intevac Inc
IVAC
$2.2K ﹤0.01%
300
-900
-75% -$6.33K
MOBVW
14096
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$2.2K ﹤0.01%
39,984
+402
+1% +$19
CRDL
14097
CALL
Cardiol Therapeutics
CRDL
$207M
$2.19K ﹤0.01%
4,500
-23,900
-84% -$14.1K
EMX
14098
PUT
DELISTED
EMX Royalty
EMX
$2.19K ﹤0.01%
1,100
AVD icon
14099
CALL
American Vanguard Corp
AVD
$62.5M
$2.19K ﹤0.01%
100
-3,700
-97% -$79.7K
GMDA
14100
PUT
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$2.19K ﹤0.01%
2,700
-1,900
-41% -$2.78K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.